Title: Evaluating the Efficacy of 8 Non-invasive Models in Predicting MASLD and Its
Progression: A Prospective Study
Version: 3 Date: 27 Jul 2024
Reviewer's report:
This paper analyzes and compares eight noninvasive models to predict intrahepatic steatosis and
progression well.
Hepatic fibrosis is an important predictor of prognosis in MASLD, and this study is less novel in
its approach to the disease because it focuses on steatosis. However, the content of this paper is
useful in the practical diagnosis and management of patients presenting to the clinic, as steatosis
is important in addition to hepatic fibrosis of MASLD.
Title: Evaluating the Efficacy of 8 Non-invasive Models in Predicting MASLD and Its
Progression: A Prospective Study
Version: 3 Date: 27 Jul 2024
Reviewer's report:
This paper analyzes and compares eight noninvasive models to predict intrahepatic steatosis and
progression well.
Hepatic fibrosis is an important predictor of prognosis in MASLD, and this study is less novel in
its approach to the disease because it focuses on steatosis. However, the content of this paper is
useful in the practical diagnosis and management of patients presenting to the clinic, as steatosis
is important in addition to hepatic fibrosis of MASLD.
Please review this paper.
user
Title: Evaluating the Efficacy of 8 Non-invasive Models in Predicting MASLD and Its
Progression: A Prospective Study
Version: 3 Date: 27 Jul 2024
Reviewer's report:
This paper analyzes and compares eight noninvasive models to predict intrahepatic steatosis and
progression well.
Hepatic fibrosis is an important predictor of prognosis in MASLD, and this study is less novel in
its approach to the disease because it focuses on steatosis. However, the content of this paper is
useful in the practical diagnosis and management of patients presenting to the clinic, as steatosis
is important in addition to hepatic fibrosis of MASLD.
assistant